Table 3.
High Arousal Positive Affect and Related Covariates as Predictors of sTNF-RII in a Two-Level Multilevel Model using Restricted Maximum Likelihood (REML) Estimation (n = 186)
| sTNF-RII | |||
|---|---|---|---|
|
| |||
| B | SE | P value | |
| Intercept | 7.760 | .133 | <.001 |
| Time | −.006 | .013 | .634 |
| High Arousal Positive Affect | −.030 | .025 | .218 |
| Negative Affect | −.007 | .003 | .022 |
| Age | .008 | .003 | .014 |
| Body Mass Index (BMI) | .006 | .003 | .081 |
| Fatigue Severity | .025 | .010 | .012 |
| Cancer Stage (0 is reference group) | |||
| I | .034 | .061 | .574 |
| II | .057 | .072 | .432 |
| III | .094 | .089 | .292 |
| Menopausal Status | |||
| (Post-menopausal before cancer is reference group) | |||
| Premenopausal | −.039 | .057 | .497 |
| Treatment-induced Menopause | .006 | .061 | .921 |
| Months since Last Treatment | −.032 | .020 | .119 |
| Radiation Therapy | −.019 | .046 | .674 |
| Endocrine Therapy | −.054 | .018 | .003 |
| Chemotherapy | .090 | .056 | .108 |
| Time*Chemotherapy | −.075 | .015 | <.001 |